Stay updated with breaking news from Objective Response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Strategic Collaborator-presented Phase 1 Pancreatic Cancer Data An ongoing Phase 1, collaborator-led study of NBTXR3 in locally advanced pancreatic cancer established a favorable safety profile and...
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...
/PRNewswire/ -- Syntrix Pharmaceuticals today announced results from a single-arm, open-label Phase 1 trial of single-agent SX-682, an investigational CXCR1/2...
07.11.2022 - Results show strong signals of clinical responses in patients with advanced cervical cancer who received up to 2 prior lines of therapyOSLO, Norway, Nov. 07, 2022 (GLOBE NEWSWIRE) - Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage ... Seite 1
/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced detailed results from the global Phase 3 CodeBreaK 200 trial, which showed once-daily oral...